Thalidomide combined with chemo-radiotherapy for treating esophageal cancer: A randomized controlled study.

Wang, Jian; Yu, Jingping; Wang, Jianlin; Ni, Xinchu; Sun, Zhiqiang; Sun, Wei; Sun, Suping; Lu, Yuting

Wang, Jian; Yu, Jingping; Wang, Jianlin; Ni, Xinchu; Sun, Zhiqiang; Sun, Wei; Sun, Suping; Lu, Yuting.

Afiliação

Wang J; Department of Radiotherapy, Jiangyin People's Hospital, Jiangyin, Jiangsu 214400, P.R. China.
Yu J; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Wang J; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Ni X; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Sun Z; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Sun W; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Sun S; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China.
Lu Y; Department of Radiotherapy, Xuzhou No. 3 People's Hospital, Xuzhou, Jiangsu 221000, P.R. China.

Oncol Lett ; 18(1): 804-813, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31289557

Palavras-chave

chemo-radiotherapy; esophageal cancer; prognosis; thalidomide; vascular endothelial growth factor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2019 Tipo de documento: Article País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google